Search

The Joint Commission recently issued a series of Frequently Asked Questions (FAQs) about their revised National Patient Safety Goal, NPSG.03.05.0...

Sources:
  • The Joint Commission
Relevant To:
  • Critical Access Hospitals,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care

The Joint Commission (TJC) recently released a series of FAQs that clarify NPSG.03.05.01 for Ambulatory, Hospital, Critical Access Hospital and N...

Sources:
  • The Joint Commission
Relevant To:
  • Critical Access Hospitals,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care

Novartis is voluntarily recalling of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension ...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The Joint Commission requires that accredited organizations confirm and verify the information for any individual seeking privileges. According t...

Sources:
  • The Joint Commission
Relevant To:
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care

The US Centers for Disease Control and Prevention (CDC) has developed a digital toolkit to support providers during the current multi-state measl...

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

The U.S. Food and Drug Administration (FDA) has issued a safety communication to alert health care providers and patients about issues that may c...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The US Centers for Medicare and Medicaid Services (CMS) has released a draft memorandum seeking to provide clarity about how CMS and State Agency...

Sources:
  • Centers for Medicare and Medicaid Services
Relevant To:
  • Critical Access Hospitals,
  • Hospitals

Endo International plc, has announced that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of Mycophen...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The US Food and Drug Administration (FDA) is informing health care professionals of Sagent Pharmaceuticals, Inc. voluntary nationwide recall of o...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) has released the final conscience rule that protects individ...

Sources:
  • Department of Health and Human Services
Relevant To:
  • All Healthcare Organizations

The US Department of Health and Human Services (HHS) recently issued a notice of enforcement discretion regarding HIPAA civil monetary penalties....

Sources:
  • Department of Health and Human Services
Relevant To:
  • All Healthcare Organizations

Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The US Food and Drug Administration (FDA) is advising that rare but serious injuries have happened with certain common prescription insomnia medi...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

AmEx Pharmacy is voluntarily recalling one Lot of Bevacizumab 1.25mg/0.05mL 31G Injectable to the consumer/user level. The Monoject Syringe of th...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations

The U.S. Food and Drug Administration (FDA) is aware of recent incidents that caused excess radiation exposure to patients due to user error with cert...

Sources:
  • Food and Drug Administration
Relevant To:
  • All Healthcare Organizations